Table 1.
Cohort characteristics, demographics, and follow-up times.
| N = 279 subjects in the AUSLONG study, with 3065 repeated EDSS observations. N = 253 subjects included in the analysis, 2453 repeated EDSS observations. Nmiss = 471 missing EDSS points that were omitted in the analysis. D1 = 481 valid worsening events. D2 = 856 relapsing events. | ||
|---|---|---|
| Overall data | ||
| Female/male | 196/57 | 253 |
| Mean age at onset female/male (yrs) | 37.6/37.4 | 37.5 |
| Median EDSS at onset female/male | 2.5/2.0 | 2.5 |
| Median EDSS at diagnosis female/male | 3.5/2.5 | 3.0 |
| Median EDSS at year 10 female/male | 5.0/5.0 | 6.0 |
| Average follow‐up from onset female/male (yrs) | 8.8/8.2 | 8.5 |
| Average follow‐up from diagnosis female/male (yrs) | 7.1/7.9 | 7.5 |
| Average time to first relapse female/male (mnths) | 8.4/6.7 | 7.6 |
| Mean T2L count at baseline female/male | 8.5/8.0 | 8.3 |
| Relapse rates per year female/male | 0.2/0.3 | 0.3 |
| Mean body mass index at baseline female/male | 26.4/28.9 | 27.7 |
| Mean body mass index at year 10 female/male | 27.0/28.3 | 27.7 |
| Average disease duration at year 10 female/male (yrs) | 9.9/8.6 | 9.3 |